These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15710608)
1. Substrate-induced interconversion of protein quaternary structure isoforms. Tang L; Stith L; Jaffe EK J Biol Chem; 2005 Apr; 280(16):15786-93. PubMed ID: 15710608 [TBL] [Abstract][Full Text] [Related]
2. Single amino acid mutations alter the distribution of human porphobilinogen synthase quaternary structure isoforms (morpheeins). Tang L; Breinig S; Stith L; Mischel A; Tannir J; Kokona B; Fairman R; Jaffe EK J Biol Chem; 2006 Mar; 281(10):6682-90. PubMed ID: 16377642 [TBL] [Abstract][Full Text] [Related]
3. Porphobilinogen synthase: An equilibrium of different assemblies in human health. Jaffe EK Prog Mol Biol Transl Sci; 2020; 169():85-104. PubMed ID: 31952692 [TBL] [Abstract][Full Text] [Related]
4. The Remarkable Character of Porphobilinogen Synthase. Jaffe EK Acc Chem Res; 2016 Nov; 49(11):2509-2517. PubMed ID: 27783504 [TBL] [Abstract][Full Text] [Related]
5. Kinetics and thermodynamics of the interchange of the morpheein forms of human porphobilinogen synthase. Selwood T; Tang L; Lawrence SH; Anokhina Y; Jaffe EK Biochemistry; 2008 Mar; 47(10):3245-57. PubMed ID: 18271513 [TBL] [Abstract][Full Text] [Related]
6. Probing the oligomeric assemblies of pea porphobilinogen synthase by analytical ultracentrifugation. Kokona B; Rigotti DJ; Wasson AS; Lawrence SH; Jaffe EK; Fairman R Biochemistry; 2008 Oct; 47(40):10649-56. PubMed ID: 18795796 [TBL] [Abstract][Full Text] [Related]
7. Allosteric inhibition of human porphobilinogen synthase. Lawrence SH; Ramirez UD; Selwood T; Stith L; Jaffe EK J Biol Chem; 2009 Dec; 284(51):35807-17. PubMed ID: 19812033 [TBL] [Abstract][Full Text] [Related]
8. Morpheeins--a new structural paradigm for allosteric regulation. Jaffe EK Trends Biochem Sci; 2005 Sep; 30(9):490-7. PubMed ID: 16023348 [TBL] [Abstract][Full Text] [Related]
9. Control of tetrapyrrole biosynthesis by alternate quaternary forms of porphobilinogen synthase. Breinig S; Kervinen J; Stith L; Wasson AS; Fairman R; Wlodawer A; Zdanov A; Jaffe EK Nat Struct Biol; 2003 Sep; 10(9):757-63. PubMed ID: 12897770 [TBL] [Abstract][Full Text] [Related]
11. Allostery and the dynamic oligomerization of porphobilinogen synthase. Jaffe EK; Lawrence SH Arch Biochem Biophys; 2012 Mar; 519(2):144-53. PubMed ID: 22037356 [TBL] [Abstract][Full Text] [Related]
12. Biochemical and molecular characterization of a novel porphobilinogen synthase from Corynebacterium glutamicum. Zhu D; Wu C; Niu C; Li H; Ge F; Li W World J Microbiol Biotechnol; 2023 Apr; 39(6):165. PubMed ID: 37071336 [TBL] [Abstract][Full Text] [Related]
14. Docking to large allosteric binding sites on protein surfaces. Ramirez UD; Myachina F; Stith L; Jaffe EK Adv Exp Med Biol; 2010; 680():481-8. PubMed ID: 20865533 [TBL] [Abstract][Full Text] [Related]
15. Rhodobacter capsulatus porphobilinogen synthase, a high activity metal ion independent hexamer. Bollivar DW; Clauson C; Lighthall R; Forbes S; Kokona B; Fairman R; Kundrat L; Jaffe EK BMC Biochem; 2004 Nov; 5():17. PubMed ID: 15555082 [TBL] [Abstract][Full Text] [Related]
16. Mechanistic implications of mutations to the active site lysine of porphobilinogen synthase. Mitchell LW; Volin M; Martins J; Jaffe EK J Biol Chem; 2001 Jan; 276(2):1538-44. PubMed ID: 11032841 [TBL] [Abstract][Full Text] [Related]
17. Production, purification, and characterization of a Mg2+-responsive porphobilinogen synthase from Pseudomonas aeruginosa. Frankenberg N; Heinz DW; Jahn D Biochemistry; 1999 Oct; 38(42):13968-75. PubMed ID: 10529243 [TBL] [Abstract][Full Text] [Related]
18. Redox and metal-regulated oligomeric state for human porphobilinogen synthase activation. Sawada N; Nagahara N; Arisaka F; Mitsuoka K; Minami M Amino Acids; 2011 Jun; 41(1):173-80. PubMed ID: 20354739 [TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa contains a novel type V porphobilinogen synthase with no required catalytic metal ions. Frankenberg N; Jahn D; Jaffe EK Biochemistry; 1999 Oct; 38(42):13976-82. PubMed ID: 10529244 [TBL] [Abstract][Full Text] [Related]
20. Impact of quaternary structure dynamics on allosteric drug discovery. Jaffe EK Curr Top Med Chem; 2013; 13(1):55-63. PubMed ID: 23409765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]